Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Maraviroc MeSH Descriptor Data 2025


MeSH Heading
Maraviroc
Tree Number(s)
D02.455.426.392.368.367.726
D03.383.129.799.682
Unique ID
D000077592
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077592
Scope Note
A cyclohexane and triazole derivative that acts as an antagonist of the CCR5 RECEPTOR. It prevents infection by HIV-1 virus strains which use CCR5 as a co-receptor for membrane fusion and cellular entry.
Entry Term(s)
4,4-Difluoro-N-((1S)-3-(exo-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)oct-8-yl)-1-phenylpropyl)cyclohexanecarboxamide
Selzentry
UK-427,857
UK-427857
Pharm Action
HIV Fusion Inhibitors
CCR5 Receptor Antagonists
Registry Numbers
MD6P741W8A
0
CAS Type 1 Name
Cyclohexanecarboxamide, 4,4-difluoro-N-((1S)-3-((3-exo)-3-(3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)oct-8-yl)-1-phenylpropyl)-
Public MeSH Note
2019; MARAVIROC was indexed under CYCLOHEXANES and TRIAZOLES 2005-2018
History Note
2019 (2005)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/04/09
Maraviroc Preferred
UK-427,857 Narrower
Selzentry Narrower
page delivered in 0.146s